Form 4: Inspire Medical Systems Director Exercises Options and Sells Shares Under 10b5-1 Plan

Director Jerry C. Griffin exercised stock options and sold shares of Inspire Medical Systems, Inc. under a pre-arranged 10b5-1 trading plan.

Summary

• On March 18, 2024, Jerry C. Griffin, a director of Inspire Medical Systems, Inc., exercised stock options to acquire 1,000 shares of common stock at a price of $16 per share.
• Simultaneously, Griffin sold 54 shares at $193.53 and 500 shares at $193.53.
• These transactions were executed under a 10b5-1 trading plan adopted on November 30, 2023.
• Following these transactions, Griffin directly owns 10,190 shares of Inspire Medical Systems, Inc.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transactions are part of a pre-planned trading strategy and do not necessarily indicate a change in the director's confidence in the company.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, indicating a planned and transparent approach to stock transactions.

Industry Context

Executive stock transactions are common and closely monitored, especially in the medical device industry. The use of 10b5-1 plans is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• Stock option exercises and sales by executives are a common practice across publicly traded companies, including those in the medical device sector.
• Companies like Medtronic and Boston Scientific also see regular Form 4 filings related to executive stock transactions.
• The use of 10b5-1 trading plans is a widely accepted method for executives to manage their stock holdings in a compliant manner.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the small number of shares involved.
• The use of a 10b5-1 plan ensures transparency and reduces the risk of insider trading concerns.

Key Dates